benzinga
HC Wainwright & Co. Reiterates Buy on Trevi Therapeutics, Maintains $21 Price Target
📈
AI Sentiment
Highly Positive
8/10
Dow Jones
Updated 2 minutes ago
$47,125.36
-$369.89 -0.78%
92.0% of range
Low $36,611.78
Current $47,125.36
High $48,040.64
NASDAQ
Updated 2 minutes ago
$22,380.72
-$18.27 -0.08%
82.3% of range
Low $14,784.03
Current $22,380.72
High $24,019.99
S&P 500
Updated 2 minutes ago
$6,713.75
-$20.87 -0.31%
90.1% of range
Low $4,835.04
Current $6,713.75
High $6,920.34
Russell 2000
Updated 2 minutes ago
$2,499.67
-$19.69 -0.78%
94.8% of range
Low $1,732.99
Current $2,499.67
High $2,541.67
Sector Performance
Real-time sector performance overview View All Sectors
Industrials
+5.39%
501
118
339
Market Cap:$6.63T
Volume:199.62M
Consumer Discretionary
+3.42%
905
168
664
Market Cap:$16.16T
Volume:532.35M
Health Care
+3.40%
900
429
401
Market Cap:$8.39T
Volume:375.73M
Energy
+1.19%
170
99
58
Market Cap:$3.09T
Volume:207.37M
Crypto
+0.02%
23
11
9
Market Cap:$0.00
Volume:440.54M
Utilities
-0.24%
129
46
76
Market Cap:$2.48T
Volume:62.18M
Telecommunications
-0.49%
76
22
48
Market Cap:$1.73T
Volume:111.07M
Technology
-0.69%
640
191
395
Market Cap:$35.18T
Volume:512.91M
Daily FinQuota Stock Market Highlights
Stocks with the Highest Price Increases
Stocks with the Highest Price Drops
Stocks Hitting New 52-Week Lows Today
Stocks Hitting New 52-Week Highs Today
Stocks at 52-Week Lows
Upcoming Earnings
Insider Trading Activity
View Insider Activity Pan Anthony X
Buy
Other
ACNT Mar 6, 2026
Avg Cost/Share
$13.31
Shares
3,400
Total Value
$45,234.50
Owned After
20,651
ELMS STEVE
Buy
Director
ADMA Mar 6, 2026
Avg Cost/Share
$15.39
Shares
7,000
Total Value
$107,730.00
Owned After
2,045,730
SEC Form 4
Chernett Jorey
Buy
10% Owner
AIRS Mar 6, 2026
Avg Cost/Share
$2.00
Shares
45,600
Total Value
$91,200.00
Owned After
6,398,211
SEC Form 4
WEAVER GREGORY L
Buy
Chief Financial Officer
ALT Mar 6, 2026
Avg Cost/Share
$3.54
Shares
5,000
Total Value
$17,700.00
Owned After
28,078
SEC Form 4
Durso Jerome Benedict
Buy
President and CEO
ALT Mar 6, 2026
Avg Cost/Share
$3.54
Shares
20,000
Total Value
$70,790.00
Owned After
32,500
SEC Form 4
Richmond C Bradford
Buy
Director
BJRI Mar 6, 2026
Avg Cost/Share
$34.50
Shares
1,000
Total Value
$34,500.00
Owned After
17,700
SEC Form 4
Sams Louise S
Buy
Director
CSGP Mar 6, 2026
Avg Cost/Share
$48.36
Shares
1,000
Total Value
$48,360.00
Owned After
20,409
SEC Form 4
ANGEL STEPHEN F
Buy
President & CEO
CSX Mar 6, 2026
Avg Cost/Share
$40.27
Shares
25,000
Total Value
$1,006,750.00
Owned After
146,540
SEC Form 4
Painter John P II
Buy
Director
CZFS Mar 6, 2026
Avg Cost/Share
$61.00
Shares
675
Total Value
$41,175.00
Owned After
3,412.017
SEC Form 4
Pennell Sandra
Buy
Chief Financial Officer
DCTH Mar 6, 2026
Avg Cost/Share
$9.04
Shares
5,533
Total Value
$50,018.32
Owned After
77,018
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Pan Anthony X | ACNT | Other | Mar 6, 2026 | Buy | $13.31 | 3,400 | $45,234.50 | 20,651 | |
| ELMS STEVE | ADMA | Director | Mar 6, 2026 | Buy | $15.39 | 7,000 | $107,730.00 | 2,045,730 | |
| Chernett Jorey | AIRS | 10% Owner | Mar 6, 2026 | Buy | $2.00 | 45,600 | $91,200.00 | 6,398,211 | |
| WEAVER GREGORY L | ALT | Chief Financial Officer | Mar 6, 2026 | Buy | $3.54 | 5,000 | $17,700.00 | 28,078 | |
| Durso Jerome Benedict | ALT | President and CEO | Mar 6, 2026 | Buy | $3.54 | 20,000 | $70,790.00 | 32,500 | |
| Richmond C Bradford | BJRI | Director | Mar 6, 2026 | Buy | $34.50 | 1,000 | $34,500.00 | 17,700 | |
| Sams Louise S | CSGP | Director | Mar 6, 2026 | Buy | $48.36 | 1,000 | $48,360.00 | 20,409 | |
| ANGEL STEPHEN F | CSX | President & CEO | Mar 6, 2026 | Buy | $40.27 | 25,000 | $1,006,750.00 | 146,540 | |
| Painter John P II | CZFS | Director | Mar 6, 2026 | Buy | $61.00 | 675 | $41,175.00 | 3,412.017 | |
| Pennell Sandra | DCTH | Chief Financial Officer | Mar 6, 2026 | Buy | $9.04 | 5,533 | $50,018.32 | 77,018 |
Latest Market News
benzinga
The ETF Trade Of 2026 Has Nothing To Do With AI, Nvidia Or Magnificent 7
📈
AI Sentiment
Highly Positive
8/10
benzinga
Needham Reiterates Buy on Cartesian Therapeutics, Maintains $42 Price Target
📈
AI Sentiment
Highly Positive
8/10
benzinga
Why Is Olema Pharmaceuticals Stock Dropping On Monday?
📈
AI Sentiment
Highly Positive
10/10
Latest Trading Blog Posts
Expert insights, market analysis, and trading strategies
3 min read
What RSI Level is Considered Oversold?
When it comes to trading, the Relative Strength Index (RSI) is a crucial tool for identifying potential market reversals. Understanding RSI levels and their implications can help traders make informed decisions and improve their success rates. This guide will explain what RSI is, how it works, and specifically, what level is considered oversold.
3 min read
How Many Stock Trading Days Are There in 2025?
If you're an investor or a financial enthusiast planning your trading strategy for the year 2025, one of the fundamental details you need to know is the number of stock trading days in that year. Understanding this can help optimize your trading strategies, manage your portfolio effectively, and predict market activity. In this article, we delve into how many stock trading days there are in 2025 and explore the implications for investors.
3 min read
Which Trading Platform Allows Instant Deposit?
In the fast-paced world of trading, speed can be the deciding factor between capitalizing on a lucrative opportunity or missing out. For traders, having a trading platform that allows for instant deposit can greatly enhance their ability to act quickly on volatile market movements.
3 min read
What Is MACD in Stock Trading?
The Moving Average Convergence Divergence (MACD) is a powerful and widely used technical analysis tool in stock trading. It helps traders identify potential buy or sell signals based on the relationship between two moving averages of a stock's price. Whether you’re a beginner or an experienced trader, understanding MACD can significantly enhance your trading strategy.